I think a key factor is what kinds of injuries and medical conditions are included or excluded from the protocol. If the parameters aren’t exceedingly tight, 100 could take MUCH less than a year to enroll. But they do need to get through IRBs before enrollment can begin, but a hospital IRB that already worked with ReCell wouldn’t give it the same kind of thorough review as one that didn’t.
- Forums
- ASX - By Stock
- AVH
- Ann: Pivotal Soft Tissue Trial Receives US FDA IDE Approval
AVH
avita medical inc.
Add to My Watchlist
2.68%
!
$1.73

Ann: Pivotal Soft Tissue Trial Receives US FDA IDE Approval, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.73 |
Change
0.045(2.68%) |
Mkt cap ! $122.9M |
Open | High | Low | Value | Volume |
$1.71 | $1.74 | $1.70 | $650.7K | 379.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $1.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.73 | 1506 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 1.710 |
1 | 882 | 1.700 |
1 | 10000 | 1.695 |
5 | 32091 | 1.690 |
4 | 8400 | 1.680 |
Price($) | Vol. | No. |
---|---|---|
1.730 | 1506 | 1 |
1.735 | 578 | 1 |
1.750 | 11785 | 2 |
1.775 | 7364 | 3 |
1.800 | 37 | 1 |
Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |